Healthcare Sector Stocks
The Healthcare sector has a total of 1047 stocks, with a combined market cap of $9.75 trillion, total revenue of $4.73 trillion and a weighted average PE ratio of 45.77.
Market Cap
9.75T
Revenue
4.73T
Profits
212.93B
PE Ratio
45.77
Profit Margin
4.50%
Dividend Yield
0.38%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.24T | -1.59% | 1,115,133 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 665.21B | -0.85% | 1,991,647 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 509.94B | -1.48% | 1,676,066 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 342.84B | -3.00% | 3,528,160 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 321.82B | -7.83% | 6,634,791 | 450.06B |
| 6 | NVS | Novartis AG | 294.43B | -1.91% | 1,245,346 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 279.00B | -1.40% | 711,202 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 256.57B | 0.83% | 816,744 | 47.35B |
| 9 | AMGN | Amgen Inc. | 241.75B | -2.40% | 938,321 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 210.24B | -0.45% | 1,693,781 | 30.99B |
| 11 | ABT | Abbott Laboratories | 181.20B | -0.09% | 2,720,225 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 174.26B | -2.63% | 8,408,683 | 50.70B |
| 13 | PFE | Pfizer Inc. | 160.68B | -0.98% | 13,655,682 | 63.62B |
| 14 | DHR | Danaher Corporation | 160.31B | 0.93% | 842,473 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 148.01B | -0.82% | 681,552 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 135.99B | 0.41% | 398,278 | 12.95B |
| 17 | MCK | McKesson Corporation | 124.39B | -1.31% | 190,458 | 418.79B |
| 18 | MDT | Medtronic plc | 124.01B | -1.00% | 2,636,132 | 37.54B |
| 19 | BMY | Bristol-Myers Squibb Company | 122.99B | -1.92% | 2,711,053 | 50.03B |
| 20 | SYK | Stryker Corporation | 121.39B | 0.42% | 989,694 | 26.30B |
| 21 | SNY | Sanofi | 113.80B | -0.38% | 1,210,650 | 57.89B |
| 22 | CVS | CVS Health Corporation | 106.66B | -2.85% | 6,740,685 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 101.12B | -3.41% | 480,646 | 78.70B |
| 24 | GSK | GSK plc | 98.18B | -0.87% | 1,062,707 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 95.43B | -0.71% | 272,974 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 88.36B | -5.75% | 833,818 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 82.58B | -1.32% | 3,381,386 | 2.53B |
| 28 | CI | The Cigna Group | 75.68B | -2.33% | 742,357 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 68.12B | -1.11% | 1,512,355 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.49B | -0.61% | 279,556 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 64.65B | 0.17% | 359,455 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 63.27B | 1.44% | 5,548,304 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 60.76B | 0.23% | 1,226,057 | 6.67B |
| 34 | ARGX | argenx SE | 58.88B | -0.08% | 115,599 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 58.78B | 0.17% | 404,293 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 55.46B | 1.98% | 122,254 | 4.66B |
| 37 | MDLN | Medline Inc. | 51.46B | 3.82% | 26,718,458 | 30.68B |
| 38 | A | Agilent Technologies, Inc. | 49.61B | 2.17% | 636,427 | 7.37B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 49.42B | -0.63% | 3,127,578 | 17.23B |
| 40 | HUM | Humana Inc. | 48.68B | -8.58% | 1,477,403 | 154.19B |
| 41 | ONC | BeOne Medicines AG | 46.44B | -1.62% | 104,687 | 6.45B |
| 42 | VEEV | Veeva Systems Inc. | 45.67B | -2.20% | 472,676 | 3.46B |
| 43 | WAT | Waters Corporation | 45.62B | 3.20% | 193,325 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 42.61B | 0.38% | 384,466 | 17.31B |
| 45 | NTRA | Natera, Inc. | 41.43B | -0.61% | 760,197 | 2.91B |
| 46 | HLN | Haleon plc | 40.00B | 0.55% | 9,074,265 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 39.70B | 0.79% | 897,741 | 2.62B |
| 48 | GEHC | GE HealthCare Technologies Inc. | 37.76B | 2.04% | 1,060,291 | 21.64B |
| 49 | BIIB | Biogen Inc. | 37.28B | 0.57% | 325,247 | 10.30B |
| 50 | ALC | Alcon Inc. | 35.58B | 0.49% | 1,875,925 | 10.98B |
| 51 | RVMD | Revolution Medicines, Inc. | 34.90B | -0.82% | 914,529 | 197.56M |
| 52 | MTD | Mettler-Toledo International Inc. | 34.56B | 1.44% | 59,134 | 4.20B |
| 53 | ZTS | Zoetis Inc. | 34.42B | 1.49% | 1,572,663 | 9.49B |
| 54 | RMD | ResMed Inc. | 34.28B | 2.47% | 350,877 | 5.73B |
| 55 | CNC | Centene Corporation | 34.07B | -5.16% | 1,735,675 | 180.41B |
| 56 | GMAB | Genmab A/S | 32.36B | -0.90% | 1,375,847 | 4.30B |
| 57 | ILMN | Illumina, Inc. | 31.95B | 4.29% | 540,892 | 4.54B |
| 58 | DXCM | DexCom, Inc. | 30.82B | 0.74% | 1,167,128 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 30.01B | 0.35% | 151,576 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 29.33B | 0.28% | 761,774 | 20.16B |
| 61 | DGX | Quest Diagnostics Incorporated | 28.62B | 1.49% | 360,665 | 11.84B |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.20B | -2.25% | 141,571 | 3.40B |
| 63 | ROIV | Roivant Sciences Ltd. | 28.06B | 0.05% | 1,262,553 | 41.08M |
| 64 | INSM | Insmed Incorporated | 26.58B | -0.59% | 525,693 | 1.52B |
| 65 | STE | STERIS plc | 25.18B | 0.73% | 144,597 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 24.79B | -0.36% | 103,156 | 3.19B |
| 67 | INCY | Incyte Corporation | 24.32B | 0.18% | 304,752 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.77B | 1.39% | 4,782,353 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 21.92B | -2.37% | 500,031 | 22.15B |
| 70 | BNTX | BioNTech SE | 20.97B | -0.33% | 518,531 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.41B | -2.65% | 915,995 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 20.00B | 3.19% | 781,867 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.51B | 1.00% | 731,297 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.20B | -0.35% | 62,952 | 2.84B |
| 75 | ASND | Ascendis Pharma A/S | 17.86B | 0.41% | 197,421 | 1.37B |
| 76 | RVTY | Revvity, Inc. | 17.02B | 3.19% | 261,572 | 2.94B |
| 77 | EXEL | Exelixis, Inc. | 16.92B | 1.26% | 602,923 | 2.50B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.40B | -2.32% | 480,754 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.02B | 0.67% | 180,331 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.83B | 2.47% | 166,540 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.16B | 1.35% | 517,149 | 945.54M |
| 82 | SOLV | Solventum Corporation | 14.80B | 1.31% | 262,391 | 8.16B |
| 83 | ICLR | ICON Public Limited Company | 14.67B | 0.44% | 148,995 | 8.23B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 14.53B | -0.10% | 654,948 | 15.25B |
| 85 | GKOS | Glaukos Corporation | 14.19B | -1.41% | 310,475 | 690.33M |
| 86 | BAX | Baxter International Inc. | 13.61B | 2.10% | 1,339,847 | 11.61B |
| 87 | ELAN | Elanco Animal Health Incorporated | 13.39B | 3.60% | 1,825,485 | 5.15B |
| 88 | EHC | Encompass Health Corporation | 13.33B | -1.51% | 234,793 | 6.34B |
| 89 | SNN | Smith & Nephew plc | 12.70B | -0.39% | 721,853 | 6.30B |
| 90 | RDY | Dr. Reddy's Laboratories Limited | 12.65B | 1.59% | 690,750 | 3.44B |
| 91 | PEN | Penumbra, Inc. | 12.63B | 0.40% | 100,206 | 1.56B |
| 92 | BMRN | BioMarin Pharmaceutical Inc. | 11.76B | 3.79% | 1,060,791 | 3.66B |
| 93 | TEM | Tempus AI, Inc. | 11.76B | 1.66% | 2,427,136 | 1.51B |
| 94 | ALGN | Align Technology, Inc. | 11.57B | 0.46% | 251,006 | 4.16B |
| 95 | COO | The Cooper Companies, Inc. | 11.57B | 0.16% | 589,171 | 4.24B |
| 96 | TECH | Bio-Techne Corporation | 11.43B | 0.21% | 1,414,408 | 1.23B |
| 97 | RGEN | Repligen Corporation | 11.08B | 6.89% | 571,133 | 805.61M |
| 98 | HALO | Halozyme Therapeutics, Inc. | 11.02B | 0.74% | 583,479 | 1.80B |
| 99 | FMS | Fresenius Medical Care AG | 10.95B | -2.70% | 1,004,990 | 22.12B |
| 100 | MOH | Molina Healthcare, Inc. | 10.94B | -5.09% | 415,668 | 42.08B |
| 101 | UHS | Universal Health Services, Inc. | 10.88B | -1.70% | 151,300 | 18.35B |
| 102 | ENSG | The Ensign Group, Inc. | 10.66B | -0.94% | 88,763 | 5.67B |
| 103 | KYMR | Kymera Therapeutics, Inc. | 10.45B | 0.76% | 212,935 | 102.24M |
| 104 | AVTR | Avantor, Inc. | 10.42B | 1.32% | 2,256,854 | 6.64B |
| 105 | DVA | DaVita Inc. | 10.32B | -5.21% | 433,911 | 14.17B |
| 106 | QGEN | Qiagen N.V. | 10.25B | -0.21% | 1,966,948 | 2.12B |
| 107 | PODD | Insulet Corporation | 9.92B | -1.65% | 423,696 | 3.19B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 9.82B | 1.91% | 64,701 | 2.59B |
| 109 | BRKR | Bruker Corporation | 9.77B | 4.30% | 607,674 | 3.51B |
| 110 | HNGE | Hinge Health, Inc. | 9.54B | 2.59% | 426,567 | 800.82M |
| 111 | GMED | Globus Medical, Inc. | 9.54B | 2.86% | 368,236 | 3.14B |
| 112 | MTRI | Mentari Therapeutics, Inc. | 9.50B | -9.66% | 10,315 | - |
| 113 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.46B | -3.46% | 298,292 | 1.43B |
| 114 | PCVX | Vaxcyte, Inc. | 9.35B | -0.61% | 419,799 | - |
| 115 | HSIC | Henry Schein, Inc. | 9.33B | 1.78% | 752,235 | 13.73B |
| 116 | KRYS | Krystal Biotech, Inc. | 9.26B | 4.63% | 110,354 | 470.03M |
| 117 | SYRE | Spyre Therapeutics, Inc. | 9.22B | 3.48% | 385,114 | - |
| 118 | TGTX | TG Therapeutics, Inc. | 9.22B | 4.93% | 711,958 | 897.76M |
| 119 | ATR | AptarGroup, Inc. | 9.02B | 1.35% | 53,026 | 3.99B |
| 120 | OSCR | Oscar Health, Inc. | 8.83B | -4.69% | 2,947,004 | 17.47B |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.66B | 1.53% | 142,908 | 7.46M |
| 122 | SMMT | Summit Therapeutics Inc. | 8.52B | -0.19% | 8,095,162 | - |
| 123 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.29B | 2.48% | 912,774 | 280.75M |
| 124 | HQY | HealthEquity, Inc. | 8.20B | -2.64% | 335,260 | 1.36B |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 8.17B | 0.38% | 145,209 | 551.69M |
| 126 | TWST | Twist Bioscience Corporation | 8.07B | 5.73% | 1,004,716 | 459.43M |
| 127 | ALKS | Alkermes plc | 7.87B | 3.04% | 548,458 | 1.75B |
| 128 | AMRX | Amneal Pharmaceuticals, Inc. | 7.64B | 3.79% | 553,315 | 3.20B |
| 129 | TXG | 10x Genomics, Inc. | 7.57B | 2.17% | 581,119 | 618.58M |
| 130 | PACS | PACS Group, Inc. | 7.52B | -2.43% | 288,261 | 5.71B |
| 131 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.51B | 0.55% | 103,686 | 945.96M |
| 132 | GRFS | Grifols, S.A. | 7.50B | -1.39% | 352,916 | 8.63B |
| 133 | BLCO | Bausch + Lomb Corporation | 7.50B | 0.67% | 225,729 | 5.42B |
| 134 | CORT | Corcept Therapeutics Incorporated | 7.48B | -2.48% | 221,907 | 963.65M |
| 135 | ABVX | ABIVAX Société Anonyme | 7.45B | 2.69% | 719,699 | 5.33M |
| 136 | CGON | CG Oncology, Inc. | 7.30B | 3.52% | 707,109 | 6.17M |
| 137 | CYTK | Cytokinetics, Incorporated | 7.17B | -0.33% | 493,589 | 113.29M |
| 138 | IBRX | ImmunityBio, Inc. | 7.17B | 7.67% | 7,640,998 | 182.57M |
| 139 | CHE | Chemed Corporation | 7.07B | -0.18% | 39,499 | 2.66B |
| 140 | AXSM | Axsome Therapeutics, Inc. | 7.07B | -1.20% | 243,487 | 865.27M |
| 141 | IMVT | Immunovant, Inc. | 6.96B | 1.20% | 210,436 | - |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.66B | 0.00% | 247,141 | 1.56B |
| 143 | ORKA | Oruka Therapeutics, Inc. | 6.64B | 1.57% | 152,790 | - |
| 144 | TFX | Teleflex Incorporated | 6.56B | 3.67% | 348,310 | 2.26B |
| 145 | BLTE | Belite Bio, Inc | 6.41B | 0.86% | 31,933 | - |
| 146 | KOD | Kodiak Sciences Inc. | 6.32B | 0.05% | 190,067 | - |
| 147 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.16B | 1.40% | 699,649 | 450.82M |
| 148 | SUPN | Supernus, Inc. | 6.06B | 0.52% | 1,046,394 | 1.37B |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.01B | 0.13% | 94,170 | 670.78M |
| 150 | LGND | Ligand Pharmaceuticals Incorporated | 5.98B | 1.77% | 79,789 | 253.83M |
| 151 | RDNT | RadNet, Inc. | 5.82B | -1.33% | 287,792 | 2.38B |
| 152 | SRRK | Scholar Rock Holding Corporation | 5.79B | 5.24% | 1,286,902 | 570.00K |
| 153 | CAI | Caris Life Sciences, Inc. | 5.64B | -1.35% | 1,217,988 | 1.05B |
| 154 | HAE | Haemonetics Corporation | 5.61B | 1.88% | 186,707 | 1.38B |
| 155 | DOCS | Doximity, Inc. | 5.52B | -0.61% | 1,024,490 | 661.58M |
| 156 | CON | Concentra Group Holdings Parent, Inc. | 5.36B | -0.07% | 211,533 | 2.34B |
| 157 | LFST | LifeStance Health Group, Inc. | 5.30B | -1.66% | 3,334,832 | 1.68B |
| 158 | WAY | Waystar Holding Corp. | 5.30B | -0.51% | 386,235 | 1.26B |
| 159 | MANE | Veradermics, Incorporated | 5.25B | -0.96% | 135,204 | - |
| 160 | LIVN | LivaNova PLC | 5.23B | 3.37% | 183,307 | 1.51B |
| 161 | LQDA | Liquidia Corporation | 5.23B | 2.27% | 401,809 | 621.87M |
| 162 | MMSI | Merit Medical Systems, Inc. | 5.16B | 1.91% | 109,484 | 1.61B |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.06B | 0.31% | 120,237 | 1.16B |
| 164 | MMED | MiniMed Group, Inc. | 4.95B | -1.07% | 1,406,989 | 3.22B |
| 165 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | 0.23% | 167,993 | 2.72M |
| 166 | COGT | Cogent Biosciences, Inc. | 4.91B | 1.22% | 842,528 | - |
| 167 | TVTX | Travere Therapeutics, Inc. | 4.91B | 0.00% | 291,641 | 651.03M |
| 168 | OPCH | Option Care Health, Inc. | 4.74B | 0.11% | 1,659,822 | 5.75B |
| 169 | ERAS | Erasca, Inc. | 4.70B | -3.60% | 2,425,906 | - |
| 170 | GRAL | GRAIL, Inc. | 4.68B | -1.62% | 167,500 | 166.60M |
| 171 | SHC | Sotera Health Company | 4.67B | 1.78% | 603,329 | 1.23B |
| 172 | ADPT | Adaptive Biotechnologies Corporation | 4.65B | 0.81% | 966,464 | 298.01M |
| 173 | IONS | Ionis Pharmaceuticals, Inc. | 4.60B | 2.39% | 903,944 | 960.09M |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.58B | -0.57% | 335,642 | - |
| 175 | BLLN | BillionToOne, Inc. | 4.49B | -3.67% | 749,422 | 436.87M |
| 176 | ICUI | ICU Medical, Inc. | 4.47B | 1.06% | 80,078 | 2.18B |
| 177 | STVN | Stevanato Group S.p.A. | 4.20B | 0.79% | 195,060 | 1.42B |
| 178 | HIMS | Hims & Hers Health, Inc. | 4.14B | 0.68% | 4,590,377 | 2.87B |
| 179 | SLS | SELLAS Life Sciences Group, Inc. | 4.12B | 5.59% | 23,194,705 | - |
| 180 | HTFL | HeartFlow, Inc. | 4.11B | -0.70% | 449,061 | 238.66M |
| 181 | CRSP | CRISPR Therapeutics AG | 4.08B | 4.88% | 1,094,983 | 25.17M |
| 182 | DFTX | Definium Therapeutics, Inc. | 3.99B | -0.92% | 669,036 | - |
| 183 | CDNA | CareDx, Inc. | 3.91B | -0.24% | 206,746 | 497.40M |
| 184 | TARS | Tarsus Pharmaceuticals, Inc. | 3.85B | -0.03% | 127,042 | 682.20M |
| 185 | NVST | Envista Holdings Corporation | 3.83B | 0.72% | 595,787 | 2.88B |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 3.80B | -0.28% | 338,472 | 7.50M |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.77B | 0.59% | 951,795 | 53.81M |
| 188 | RLAY | Relay Therapeutics, Inc. | 3.66B | 0.67% | 879,106 | 10.35M |
| 189 | ABCL | AbCellera Biologics Inc. | 3.65B | 1.36% | 1,094,720 | 67.85M |
| 190 | OGN | Organon & Co. | 3.65B | 0.00% | 1,886,661 | 6.10B |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.58B | 1.06% | 227,576 | 2.26M |
| 192 | IRON | Disc Medicine, Inc. | 3.57B | 2.31% | 189,448 | - |
| 193 | IOVA | Iovance Biotherapeutics, Inc. | 3.53B | 1.26% | 3,096,680 | 378.98M |
| 194 | SGRY | Surgery Partners, Inc. | 3.51B | 0.71% | 831,670 | 3.36B |
| 195 | ACHC | Acadia Healthcare Company, Inc. | 3.50B | -0.63% | 295,053 | 3.41B |
| 196 | ARQT | Arcutis Biotherapeutics, Inc. | 3.50B | 1.17% | 197,881 | 508.68M |
| 197 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.44B | -2.67% | 436,957 | -665.00K |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.44B | 0.33% | 1,319,019 | - |
| 199 | VRDN | Viridian Therapeutics, Inc. | 3.43B | 0.50% | 572,919 | 26.31M |
| 200 | TMDX | TransMedics Group, Inc. | 3.40B | 4.36% | 456,111 | 727.65M |
| 201 | AXGN | Axogen, Inc. | 3.39B | 2.64% | 784,196 | 266.93M |
| 202 | ELVN | Enliven Therapeutics, Inc. | 3.38B | -2.11% | 338,345 | - |
| 203 | PLSE | Pulse Biosciences, Inc. | 3.31B | 0.51% | 95,437 | 1.49M |
| 204 | WRBY | Warby Parker Inc. | 3.30B | 2.31% | 1,073,132 | 934.66M |
| 205 | IRTC | iRhythm Holdings, Inc. | 3.29B | 9.17% | 539,951 | 854.04M |
| 206 | BHC | Bausch Health Companies Inc. | 3.24B | 2.30% | 1,160,081 | 11.11B |
| 207 | NHC | National HealthCare Corporation | 3.24B | 0.43% | 37,487 | 1.58B |
| 208 | PRVA | Privia Health Group, Inc. | 3.23B | 1.06% | 1,368,369 | 2.43B |
| 209 | GRDN | Guardian Pharmacy Services, Inc. | 3.18B | -0.32% | 101,280 | 1.46B |
| 210 | ACAD | Acadia Pharmaceuticals Inc. | 3.14B | -0.74% | 568,496 | 1.20B |
| 211 | LEGN | Legend Biotech Corporation | 3.14B | 0.50% | 887,645 | 1.36B |
| 212 | XERS | Xeris Biopharma Holdings, Inc. | 3.12B | 1.73% | 1,090,243 | 368.26M |
| 213 | ADMA | ADMA Biologics, Inc. | 3.11B | 2.90% | 1,602,067 | 519.15M |
| 214 | TLX | Telix Pharmaceuticals Limited | 3.06B | 1.41% | 241,211 | 890.79M |
| 215 | DYN | Dyne Therapeutics, Inc. | 3.02B | 0.69% | 1,097,284 | - |
| 216 | VCEL | Vericel Corporation | 3.00B | 1.57% | 239,541 | 324.17M |
| 217 | DNLI | Denali Therapeutics Inc. | 2.90B | 0.44% | 447,111 | 21.38M |
| 218 | ATRC | AtriCure, Inc. | 2.85B | 1.71% | 141,754 | 589.80M |
| 219 | CELC | Celcuity Inc. | 2.77B | -2.90% | 364,246 | - |
| 220 | PGNY | Progyny, Inc. | 2.64B | -2.21% | 269,295 | 1.34B |
| 221 | MBX | MBX Biosciences, Inc. | 2.63B | -0.13% | 244,131 | - |
| 222 | XNCR | Xencor, Inc. | 2.57B | -0.54% | 172,198 | 200.49M |
| 223 | IDYA | IDEAYA Biosciences, Inc. | 2.55B | -3.80% | 465,309 | 36.54M |
| 224 | ZLAB | Zai Lab Limited | 2.53B | -4.44% | 522,889 | 441.73M |
| 225 | HCM | HUTCHMED (China) Limited | 2.49B | -3.06% | 21,498 | 549.12M |
| 226 | AVAH | Aveanna Healthcare Holdings Inc. | 2.47B | -2.79% | 635,913 | 2.68B |
| 227 | PBH | Prestige Consumer Healthcare Inc. | 2.43B | 6.43% | 205,106 | 1.17B |
| 228 | RGC | Regencell Bioscience Holdings Limited | 2.42B | 7.47% | 42,985 | - |
| 229 | NEOG | Neogen Corporation | 2.42B | 1.56% | 392,925 | 884.00M |
| 230 | NAMS | NewAmsterdam Pharma Company N.V. | 2.38B | 2.22% | 773,050 | 25.94M |
| 231 | UFPT | UFP Technologies, Inc. | 2.37B | 3.02% | 39,310 | 649.52M |
| 232 | CLOV | Clover Health Investments, Corp. | 2.37B | -6.55% | 3,452,401 | 2.74B |
| 233 | MD | Pediatrix Medical Group, Inc. | 2.36B | -0.50% | 228,567 | 1.96B |
| 234 | RCUS | Arcus Biosciences, Inc. | 2.33B | -1.28% | 1,105,052 | 100.00M |
| 235 | PRGO | Perrigo Company plc | 2.33B | 6.47% | 758,138 | 4.09B |
| 236 | ADUS | Addus HomeCare Corporation | 2.23B | 0.71% | 47,757 | 1.50B |
| 237 | PHVS | Pharvaris N.V. | 2.23B | -2.54% | 207,076 | - |
| 238 | LKFT | Lakefront Biotherapeutics NV | 2.22B | 0.04% | 79,046 | 1.13B |
| 239 | ALMR | Alamar Biosciences, Inc. | 2.21B | 3.95% | 190,164 | 114.05M |
| 240 | CLDX | Celldex Therapeutics, Inc. | 2.20B | -0.32% | 252,334 | 158.00K |
| 241 | BEAM | Beam Therapeutics Inc. | 2.18B | 5.81% | 1,324,153 | 146.64M |
| 242 | PVLA | Palvella Therapeutics, Inc. | 2.14B | 1.50% | 42,201 | - |
| 243 | ESTA | Establishment Labs Holdings Inc. | 2.11B | 1.97% | 146,722 | 264.03M |
| 244 | BKD | Brookdale Senior Living Inc. | 2.08B | -1.14% | 1,785,293 | 2.86B |
| 245 | VCYT | Veracyte, Inc. | 2.07B | 5.65% | 612,586 | 581.78M |
| 246 | SDGR | Schrödinger, Inc. | 2.05B | 6.27% | 543,482 | 269.20M |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -1.04% | 246,416 | 321.74M |
| 248 | BHVN | Biohaven Ltd. | 2.04B | 1.81% | 1,023,300 | - |
| 249 | IMNM | Immunome, Inc. | 2.03B | -0.06% | 222,029 | 4.02M |
| 250 | ARDT | Ardent Health, Inc. | 2.02B | -19.27% | 4,530,413 | 6.45B |
| 251 | AZTA | Azenta, Inc. | 2.02B | 5.54% | 210,934 | 621.70M |
| 252 | NEO | NeoGenomics, Inc. | 2.01B | 1.64% | 362,734 | 787.75M |
| 253 | TRLV | Trulieve Cannabis Corp. | 2.00B | 3.18% | 469,838 | 1.08B |
| 254 | FTRE | Fortrea Holdings Inc. | 1.97B | 3.98% | 315,640 | 2.67B |
| 255 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 1.70% | 607,892 | - |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 1.95B | 0.67% | 160,214 | 989.36M |
| 257 | SEPN | Septerna, Inc. | 1.94B | 2.20% | 104,512 | 96.27M |
| 258 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.93B | -0.13% | 830,070 | 961.51M |
| 259 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | 1.51% | 396,837 | 213.00M |
| 260 | REPL | Replimune Group, Inc. | 1.90B | 1.78% | 750,741 | - |
| 261 | ZBIO | Zenas BioPharma, Inc. | 1.89B | 0.18% | 121,151 | 11.00M |
| 262 | TRAX | First Tracks Biotherapeutics, Inc. | 1.88B | 2.69% | 351,390 | - |
| 263 | COAG | Hemab Therapeutics Holdings, Inc. | 1.87B | 2.68% | 95,641 | - |
| 264 | VERA | Vera Therapeutics, Inc. | 1.85B | -2.15% | 166,992 | 10.28M |
| 265 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | 8.46% | 14,085,894 | 68.23M |
| 266 | LYCA | Lycia Therapeutics, Inc. | 1.81B | 1.55% | 145,290 | 4.44M |
| 267 | RARE | Ultragenyx Pharmaceutical Inc. | 1.79B | 5.21% | 2,273,320 | 730.00M |
| 268 | ETON | Eton Pharmaceuticals, Inc. | 1.78B | -2.97% | 165,378 | 141.06M |
| 269 | STOK | Stoke Therapeutics, Inc. | 1.77B | 2.67% | 197,423 | 28.21M |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.77B | -1.10% | 98,082 | 140.84M |
| 271 | MAZE | Maze Therapeutics, Inc. | 1.74B | -3.07% | 212,225 | 20.00M |
| 272 | KMTS | Kestra Medical Technologies, Ltd. | 1.74B | 3.25% | 147,416 | 106.73M |
| 273 | ZYME | Zymeworks Inc. | 1.74B | -2.55% | 200,049 | 265.97M |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.74B | -0.30% | 69,823 | 269.36M |
| 275 | INSP | Inspire Medical Systems, Inc. | 1.72B | 0.07% | 127,004 | 880.94M |
| 276 | CERT | Certara, Inc. | 1.70B | 0.72% | 438,840 | 425.76M |
| 277 | XRAY | DENTSPLY SIRONA Inc. | 1.69B | -0.58% | 1,852,542 | 3.58B |
| 278 | HCSG | Healthcare Services Group, Inc. | 1.69B | 1.42% | 172,125 | 1.88B |
| 279 | BFLY | Butterfly Network, Inc. | 1.66B | 8.00% | 2,303,612 | 123.26M |
| 280 | AGL | agilon health, inc. | 1.63B | -15.89% | 158,843 | 6.00B |
| 281 | PSNL | Personalis, Inc. | 1.62B | 1.28% | 693,886 | 80.77M |
| 282 | PGEN | Precigen, Inc. | 1.60B | 3.96% | 1,387,476 | 156.94M |
| 283 | OMCL | Omnicell, Inc. | 1.60B | 2.09% | 74,194 | 1.24B |
| 284 | SNDA | Sonida Senior Living, Inc. | 1.59B | 1.04% | 135,189 | 593.56M |
| 285 | KLRA | Kailera Therapeutics, Inc. | 1.59B | 0.25% | 125,059 | - |
| 286 | SRPT | Sarepta Therapeutics, Inc. | 1.59B | 0.20% | 531,306 | 1.96B |
| 287 | BRVE | Braveheart Bio, Inc. | 1.58B | 3.04% | 116,245 | - |
| 288 | ASTH | Astrana Health, Inc. | 1.57B | -4.35% | 186,000 | 3.91B |
| 289 | ALVO | Alvotech | 1.57B | 0.46% | 523,990 | 492.31M |
| 290 | VIR | Vir Biotechnology, Inc. | 1.56B | -1.30% | 680,937 | 302.80M |
| 291 | ENOV | Enovis Corporation | 1.56B | -0.44% | 214,543 | 2.31B |
| 292 | WWB | Windward Bio Group AG | 1.55B | 3.77% | 55,867 | - |
| 293 | WGS | GeneDx Holdings Corp. | 1.54B | 8.92% | 552,774 | 460.78M |
| 294 | ADRX | ADARx Pharmaceuticals, Inc. | 1.53B | 3.73% | 357,854 | 6.13M |
| 295 | ANIP | ANI Pharmaceuticals, Inc. | 1.53B | 2.88% | 85,212 | 1.04B |
| 296 | TDOC | Teladoc Health, Inc. | 1.52B | -1.53% | 1,553,610 | 2.47B |
| 297 | MESO | Mesoblast Limited | 1.52B | -1.22% | 52,518 | 120.25M |
| 298 | NRIX | Nurix Therapeutics, Inc. | 1.51B | -2.67% | 724,135 | 701.94M |
| 299 | AMN | AMN Healthcare Services, Inc. | 1.51B | 2.78% | 136,945 | 3.52B |
| 300 | KRSA | Korsana Biosciences, Inc. | 1.48B | -0.09% | 111,871 | - |
| 301 | QURE | uniQure N.V. | 1.48B | 1.44% | 363,972 | 20.17M |
| 302 | PRCT | PROCEPT BioRobotics Corporation | 1.47B | 7.44% | 690,488 | 352.31M |
| 303 | ABSI | Absci Corporation | 1.45B | 11.02% | 2,687,999 | 1.49M |
| 304 | ALHC | Alignment Healthcare, Inc. | 1.45B | -8.92% | 3,021,416 | 4.94B |
| 305 | PAHC | Phibro Animal Health Corporation | 1.45B | 2.15% | 22,318 | 1.54B |
| 306 | CNMD | CONMED Corporation | 1.45B | 0.33% | 100,875 | 1.37B |
| 307 | USPH | U.S. Physical Therapy, Inc. | 1.44B | -0.83% | 156,817 | 829.86M |
| 308 | DMRA | Damora Therapeutics, Inc. | 1.43B | 2.53% | 226,592 | - |
| 309 | URGN | UroGen Pharma Ltd. | 1.43B | -2.28% | 374,142 | 250.25M |
| 310 | IMCR | Immunocore Holdings plc | 1.43B | -0.43% | 137,719 | 429.30M |
| 311 | NTLA | Intellia Therapeutics, Inc. | 1.41B | 2.56% | 2,275,666 | 52.89M |
| 312 | RAPP | Rapport Therapeutics, Inc. | 1.40B | -0.46% | 122,803 | 20.00M |
| 313 | ANAB | AnaptysBio, Inc. | 1.40B | 2.89% | 210,615 | 60.04M |
| 314 | NUVB | Nuvation Bio Inc. | 1.38B | 0.51% | 2,195,613 | 201.73M |
| 315 | LMRI | Lumexa Imaging Holdings, Inc. | 1.38B | -1.88% | 110,189 | 1.06B |
| 316 | TYRA | Tyra Biosciences, Inc. | 1.36B | 0.41% | 124,862 | - |
| 317 | GENB | Generate Biomedicines, Inc. | 1.35B | 6.20% | 460,717 | 21.07M |
| 318 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 3.00% | 972,062 | 5.49M |
| 319 | NBTX | Nanobiotix S.A. | 1.34B | -2.91% | 26,821 | 13.15M |
| 320 | MNKD | MannKind Corporation | 1.32B | 0.98% | 805,786 | 413.37M |
| 321 | NVAX | Novavax, Inc. | 1.32B | 0.50% | 1,922,143 | 411.65M |
| 322 | OCUL | Ocular Therapeutix, Inc. | 1.32B | -0.50% | 1,569,948 | 50.38M |
| 323 | INVA | Innoviva, Inc. | 1.31B | 0.98% | 653,814 | 438.32M |
| 324 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.30B | 4.50% | 202,427 | 745.79M |
| 325 | PNTG | The Pennant Group, Inc. | 1.29B | 0.22% | 147,025 | 1.17B |
| 326 | LBRX | LB Pharmaceuticals Inc | 1.29B | -1.46% | 185,040 | - |
| 327 | AVLN | Avalyn Pharma Inc. | 1.28B | 2.97% | 106,697 | - |
| 328 | STAA | STAAR Surgical Company | 1.28B | -0.55% | 101,809 | 328.27M |
| 329 | GPCR | Structure Therapeutics Inc. | 1.27B | -2.09% | 266,610 | - |
| 330 | NVCR | NovoCure Limited | 1.27B | -2.24% | 342,697 | 725.39M |
| 331 | SVRA | Savara Inc. | 1.27B | 5.25% | 2,452,172 | - |
| 332 | GHRS | GH Research PLC | 1.25B | -0.22% | 328,780 | - |
| 333 | OPK | OPKO Health, Inc. | 1.25B | 4.01% | 973,895 | 654.10M |
| 334 | MLYS | Mineralys Therapeutics, Inc. | 1.25B | -2.62% | 280,516 | - |
| 335 | INNV | InnovAge Holding Corp. | 1.25B | -2.97% | 129,315 | 1.02B |
| 336 | KARD | Kardigan, Inc. | 1.24B | 0.23% | 134,429 | - |
| 337 | SLN | Silence Therapeutics plc | 1.23B | 0.03% | 335,342 | 456.00K |
| 338 | TNDM | Tandem Diabetes Care, Inc. | 1.22B | 2.34% | 762,505 | 1.08B |
| 339 | HROW | Harrow, Inc. | 1.22B | 9.69% | 414,440 | 303.25M |
| 340 | NUTX | Nutex Health Inc. | 1.20B | -0.05% | 72,970 | 796.53M |
| 341 | NKTR | Nektar Therapeutics | 1.20B | -2.62% | 177,597 | 52.19M |
| 342 | CRON | Cronos Group Inc. | 1.20B | 1.25% | 452,251 | 206.20M |
| 343 | GDRX | GoodRx Holdings, Inc. | 1.18B | 0.00% | 241,353 | 785.23M |
| 344 | CMPS | COMPASS Pathways plc | 1.15B | 1.57% | 1,157,395 | - |
| 345 | AAPG | Ascentage Pharma Group International | 1.15B | -1.29% | 950 | 94.61M |
| 346 | VOR | Vor Biopharma Inc. | 1.13B | 1.21% | 319,025 | - |
| 347 | ATEC | Alphatec Holdings, Inc. | 1.12B | 4.47% | 1,054,800 | 839.72M |
| 348 | DRTS | Alpha Tau Medical Ltd. | 1.12B | 0.08% | 353,175 | - |
| 349 | FRNM | Freenome, Inc. | 1.10B | 4.58% | 325,062 | 217.86M |
| 350 | ANRO | Alto Neuroscience, Inc. | 1.10B | 9.84% | 387,207 | - |
| 351 | IART | Integra LifeSciences Holdings Corporation | 1.08B | 2.88% | 148,815 | 1.66B |
| 352 | INBX | Inhibrx Biosciences, Inc. | 1.08B | -1.63% | 85,915 | 2.00M |
| 353 | JBIO | Jade Biosciences, Inc. | 1.08B | 0.97% | 265,744 | - |
| 354 | OMER | Omeros Corporation | 1.07B | 2.80% | 760,332 | 74.36M |
| 355 | IRMD | IRADIMED CORPORATION | 1.06B | -1.08% | 28,150 | 89.34M |
| 356 | SIBN | SI-BONE, Inc. | 1.05B | 0.13% | 238,116 | 220.65M |
| 357 | CSTL | Castle Biosciences, Inc. | 1.04B | 2.64% | 212,232 | 377.13M |
| 358 | AHG | Akso Health Group | 1.04B | -2.42% | 853 | 13.83M |
| 359 | SGP | SpyGlass Pharma, Inc. | 1.02B | -2.67% | 28,248 | - |
| 360 | CBLL | CeriBell, Inc. | 1.01B | 0.21% | 118,372 | 108.72M |
| 361 | SPTX | Seaport Therapeutics, Inc. | 1.01B | 3.55% | 407,268 | - |
| 362 | AHCO | AdaptHealth Corp. | 997.92M | -0.80% | 439,931 | 3.44B |
| 363 | GMRS | GMR Solutions Inc. | 952.80M | -5.81% | 413,157 | 5.97B |
| 364 | IMTX | Immatics N.V. | 950.91M | -0.72% | 230,589 | 49.33M |
| 365 | MLTX | MoonLake Immunotherapeutics | 949.37M | -0.84% | 398,883 | - |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 933.89M | 0.57% | 50,788 | 99.00K |
| 367 | LTGO | Latigo Biotherapeutics, Inc. | 933.49M | 2.33% | 119,000 | - |
| 368 | AKTS | Aktis Oncology, Inc. | 918.99M | 0.98% | 87,770 | 12.39M |
| 369 | BVS | Bioventus Inc. | 918.44M | 2.83% | 226,805 | 585.64M |
| 370 | AORT | Artivion, Inc. | 907.49M | 1.81% | 244,906 | 481.88M |
| 371 | PHAR | Pharming Group N.V. | 891.80M | 1.99% | 2,751 | 386.75M |
| 372 | CTY | City Therapeutics, Inc. | 876.22M | 0.63% | 32,511 | 14.34M |
| 373 | VSTM | Verastem, Inc. | 865.72M | -7.29% | 1,216,382 | 100.30M |
| 374 | OMDA | Omada Health, Inc. | 864.19M | -1.07% | 289,162 | 333.04M |
| 375 | CRVS | Corvus Pharmaceuticals, Inc. | 850.28M | -0.88% | 296,385 | - |
| 376 | HSTM | HealthStream, Inc. | 841.49M | -0.58% | 67,841 | 327.95M |
| 377 | KIDS | OrthoPediatrics Corp. | 836.32M | 1.97% | 38,622 | 264.14M |
| 378 | BBTX | Bambusa Therapeutics, Inc. | 831.38M | -0.18% | 71,857 | - |
| 379 | MGTX | MeiraGTx Holdings plc | 818.00M | -1.06% | 189,635 | 401.91M |
| 380 | COLL | Collegium Pharmaceutical, Inc. | 807.96M | 1.76% | 117,953 | 815.19M |
| 381 | RIGL | Rigel Pharmaceuticals, Inc. | 805.55M | -0.33% | 77,179 | 288.21M |
| 382 | LXRX | Lexicon Pharmaceuticals, Inc. | 803.65M | 1.40% | 694,626 | 38.54M |
| 383 | ORIC | ORIC Pharmaceuticals, Inc. | 798.19M | -4.00% | 373,227 | - |
| 384 | OBX | Obsidian Therapeutics, Inc. | 793.78M | 6.46% | 357,346 | - |
| 385 | GLUE | Monte Rosa Therapeutics, Inc. | 789.99M | 1.93% | 396,636 | 70.33M |
| 386 | IRWD | Ironwood Pharmaceuticals, Inc. | 789.68M | -2.05% | 1,105,608 | 400.30M |
| 387 | ARDX | Ardelyx, Inc. | 789.31M | -1.26% | 1,401,314 | 468.22M |
| 388 | SNDX | Syndax Pharmaceuticals, Inc. | 785.95M | -5.11% | 867,398 | 289.68M |
| 389 | CTKB | Cytek Biosciences, Inc. | 774.24M | 3.86% | 269,046 | 207.65M |
| 390 | PHR | Phreesia, Inc. | 772.16M | -0.96% | 246,735 | 507.79M |
| 391 | VREX | Varex Imaging Corporation | 764.77M | 0.25% | 275,928 | 865.00M |
| 392 | BBNX | Beta Bionics, Inc. | 761.14M | -4.89% | 404,945 | 127.27M |
| 393 | APMD | Apnimed, Inc. | 755.18M | 1.91% | 108,249 | 108.80M |
| 394 | IVA | Inventiva S.A. | 748.70M | -0.47% | 1,265,508 | 2.81M |
| 395 | INMD | InMode Ltd. | 748.40M | 0.77% | 122,538 | 373.60M |
| 396 | OABI | OmniAb, Inc. | 743.89M | 0.99% | 484,828 | 40.21M |
| 397 | AURA | Aura Biosciences, Inc. | 743.09M | -0.14% | 205,423 | - |
| 398 | ATTO | Attovia Therapeutics, Inc. | 733.69M | 8.01% | 146,239 | 1.44M |
| 399 | SGMT | Sagimet Biosciences Inc. | 720.82M | 2.54% | 355,891 | - |
| 400 | PRME | Prime Medicine, Inc. | 715.58M | 4.43% | 1,731,749 | 7.06M |
| 401 | DCTH | Delcath Systems, Inc. | 701.33M | 4.08% | 179,498 | 109.96M |
| 402 | IAM | Iambic Therapeutics, Inc. | 699.16M | 3.73% | 211,718 | 18.25M |
| 403 | KURA | Kura Oncology, Inc. | 696.44M | 1.20% | 1,369,265 | 79.31M |
| 404 | FLGT | Fulgent Genetics, Inc. | 694.28M | 2.64% | 161,159 | 330.28M |
| 405 | SLDB | Solid Biosciences Inc. | 691.99M | -0.48% | 510,755 | - |
| 406 | NVCT | Nuvectis Pharma, Inc. | 679.52M | 2.92% | 97,052 | - |
| 407 | QDEL | QuidelOrtho Corporation | 669.66M | -1.11% | 455,397 | 2.59B |
| 408 | ANNX | Annexon, Inc. | 667.67M | 0.86% | 948,408 | - |
| 409 | QUIT | Achieve Life Sciences, Inc. | 667.36M | -0.90% | 342,240 | - |
| 410 | SOPH | SOPHiA GENETICS SA | 646.72M | 1.34% | 200,426 | 90.97M |
| 411 | ABUS | Arbutus Biopharma Corporation | 637.70M | 2.72% | 650,844 | 181.49M |
| 412 | JANX | Janux Therapeutics, Inc. | 637.53M | -2.71% | 331,396 | 23.29M |
| 413 | GERN | Geron Corporation | 630.84M | -2.08% | 14,427,624 | 217.52M |
| 414 | OLMA | Olema Oncology, Inc. | 629.45M | -0.48% | 356,430 | - |
| 415 | BCAX | Bicara Therapeutics Inc. | 618.40M | -2.97% | 333,430 | - |
| 416 | DBVT | DBV Technologies S.A. | 615.93M | -1.30% | 85,336 | 3.74M |
| 417 | DSGN | Design Therapeutics, Inc. | 615.39M | -2.34% | 107,438 | - |
| 418 | PACB | Pacific Biosciences of California, Inc. | 608.64M | 6.87% | 7,945,828 | 161.39M |
| 419 | SRZN | Surrozen, Inc. | 608.07M | 6.40% | 162,032 | 10.53M |
| 420 | OBIO | Orchestra BioMed Holdings, Inc. | 606.03M | 10.47% | 681,478 | 31.21M |
| 421 | IMMX | Immix Biopharma, Inc. | 603.45M | 0.00% | 299,868 | - |
| 422 | ALMS | Alumis Inc. | 597.18M | -4.96% | 592,674 | 7.24M |
| 423 | FDMT | 4D Molecular Therapeutics, Inc. | 593.68M | -2.41% | 239,041 | 96.06M |
| 424 | TCMD | Tactile Systems Technology, Inc. | 591.40M | 1.34% | 62,032 | 356.42M |
| 425 | CGEM | Cullinan Therapeutics, Inc. | 588.83M | -2.21% | 544,357 | - |
| 426 | SGHT | Sight Sciences, Inc. | 583.30M | 0.05% | 92,032 | 88.40M |
| 427 | ANL | Adlai Nortye Group Ltd. | 573.79M | -6.01% | 138,003 | 18.06M |
| 428 | SANA | Sana Biotechnology, Inc. | 566.31M | 0.53% | 1,231,429 | - |
| 429 | WVE | Wave Life Sciences, Inc. | 561.12M | 0.18% | 677,671 | 70.92M |
| 430 | ENTX | Entera Bio Ltd. | 560.72M | 7.33% | 175,774 | 42.00K |
| 431 | CLYM | Climb Bio, Inc. | 559.77M | -2.56% | 145,889 | - |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 558.15M | -0.21% | 193,600 | 147.76M |
| 433 | SENS | Senseonics Holdings, Inc. | 557.67M | 0.20% | 372,404 | 60.01M |
| 434 | CBIO | Crescent Biopharma, Inc. | 555.99M | -0.38% | 182,021 | 15.00M |
| 435 | ETRA | Electra Therapeutics, Inc. | 554.86M | 5.87% | 61,939 | - |
| 436 | AVBP | ArriVent BioPharma, Inc. | 553.44M | 0.09% | 195,041 | 5.00M |
| 437 | NRC | NRC Health | 550.17M | 0.15% | 30,751 | 143.79M |
| 438 | ACRS | Aclaris Therapeutics, Inc. | 547.21M | 2.07% | 842,891 | 6.40M |
| 439 | MYGN | Myriad Genetics, Inc. | 542.92M | 2.17% | 278,955 | 803.60M |
| 440 | RCEL | AVITA Medical, Inc. | 542.34M | 8.53% | 422,857 | 84.68M |
| 441 | DNA | Ginkgo Bioworks Holdings, Inc. | 541.22M | 0.36% | 803,708 | 130.75M |
| 442 | CAPR | Capricor Therapeutics, Inc. | 537.81M | 9.99% | 3,899,155 | 11.13M |
| 443 | EVO | Evotec SE | 536.64M | -0.34% | 21,862 | 815.72M |
| 444 | VALN | Valneva SE | 525.51M | -1.71% | 3,512 | 163.30M |
| 445 | AVR | Anteris Technologies Global Corp. | 511.35M | -1.41% | 574,738 | 2.33M |
| 446 | HELP | Helus Pharma Inc. | 507.04M | -3.61% | 1,633,202 | - |
| 447 | INDP | Indaptus Therapeutics, Inc. | 505.28M | -0.90% | 128,577 | - |
| 448 | TKNO | Alpha Teknova, Inc. | 497.56M | 3.40% | 123,722 | 45.95M |
| 449 | GYRE | Gyre Therapeutics, Inc. | 493.08M | -1.21% | 141,496 | 110.06M |
| 450 | CARL | Carlsmed, Inc. | 490.40M | 0.87% | 37,329 | 71.78M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 485.78M | 4.46% | 980,084 | 48.84M |
| 452 | RGNX | REGENXBIO Inc. | 481.04M | 0.48% | 226,062 | 153.91M |
| 453 | MNPR | Monopar Therapeutics Inc. | 479.86M | -0.35% | 56,169 | - |
| 454 | NGNE | Neurogene Inc. | 479.54M | 0.28% | 163,922 | 925.00K |
| 455 | ANGO | AngioDynamics, Inc. | 479.00M | -0.87% | 96,692 | 325.38M |
| 456 | KMDA | Kamada Ltd. | 471.65M | 0.61% | 69,037 | 196.87M |
| 457 | ASMB | Assembly Biosciences, Inc. | 469.95M | 2.00% | 219,590 | 67.01M |
| 458 | EOLS | Evolus, Inc. | 466.63M | 5.38% | 162,449 | 325.47M |
| 459 | DMAC | DiaMedica Therapeutics Inc. | 465.65M | 2.98% | 46,753 | - |
| 460 | FENC | Fennec Pharmaceuticals Inc. | 464.44M | -3.13% | 298,567 | 66.37M |
| 461 | BLSM | BlossomHill Therapeutics, Inc. | 463.11M | -3.70% | 147,189 | - |
| 462 | SRTA | Strata Critical Medical, Inc. | 462.68M | -1.15% | 321,456 | 280.76M |
| 463 | MDXG | MiMedx Group, Inc. | 462.58M | -0.31% | 461,822 | 303.73M |
| 464 | STTK | Shattuck Labs, Inc. | 457.27M | -2.18% | 757,403 | 1.00M |
| 465 | EVH | Evolent Health, Inc. | 455.82M | -12.77% | 1,996,915 | 2.34B |
| 466 | OCS | Oculis Holding AG | 446.94M | -3.60% | 117,232 | 1.12M |
| 467 | ARVN | Arvinas, Inc. | 444.97M | -0.37% | 301,687 | 275.30M |
| 468 | CTMX | CytomX Therapeutics, Inc. | 438.19M | 3.61% | 1,929,554 | 14.03M |
| 469 | OVID | Ovid Therapeutics Inc. | 437.86M | 4.50% | 1,073,751 | 1.45M |
| 470 | MOBI | Mobia Medical, Inc. | 434.60M | 3.41% | 53,853 | 51.89M |
| 471 | SI | Shoulder Innovations, Inc. | 431.11M | 0.22% | 18,145 | 64.49M |
| 472 | PRTA | Prothena Corporation plc | 430.82M | 1.57% | 221,182 | 52.74M |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 429.96M | -3.40% | 370,284 | - |
| 474 | RZLT | Rezolute, Inc. | 427.48M | 1.49% | 973,258 | - |
| 475 | CADL | Candel Therapeutics, Inc. | 418.90M | -1.11% | 743,840 | - |
| 476 | TECX | Tectonic Therapeutic, Inc. | 413.08M | 5.23% | 59,653 | - |
| 477 | PHAT | Phathom Pharmaceuticals, Inc. | 405.89M | -7.09% | 574,646 | 274.88M |
| 478 | CERS | Cerus Corporation | 402.90M | 5.00% | 2,343,981 | 226.57M |
| 479 | AVTX | Avalo Therapeutics, Inc. | 400.14M | -2.95% | 371,040 | 59.00K |
| 480 | CTEV | Claritev Corporation | 398.53M | 1.70% | 77,628 | 1.02B |
| 481 | MASS | 908 Devices Inc. | 396.90M | 1.65% | 86,622 | 65.79M |
| 482 | ALEC | Alector, Inc. | 393.04M | 3.13% | 748,669 | 173.47M |
| 483 | IRD | Opus Genetics, Inc. | 385.65M | -1.48% | 258,518 | 7.91M |
| 484 | MPLT | MapLight Therapeutics, Inc. | 373.78M | 1.22% | 113,652 | - |
| 485 | BWAY | BrainsWay Ltd. | 372.30M | -0.11% | 106,105 | 60.70M |
| 486 | CTNM | Contineum Therapeutics, Inc. | 372.24M | -0.73% | 52,313 | - |
| 487 | PBYI | Puma Biotechnology, Inc. | 368.61M | -0.14% | 124,077 | 231.83M |
| 488 | CRMD | CorMedix Inc. | 367.46M | -1.07% | 654,470 | 412.49M |
| 489 | SLBT | SL Science Holding Limited | 364.40M | 0.61% | 12,687 | 3.27M |
| 490 | CV | CapsoVision, Inc. | 361.33M | 1.35% | 54,485 | 13.92M |
| 491 | ASPE | Aspen Neuroscience, Inc. | 361.30M | 3.54% | 190,745 | - |
| 492 | SPRY | ARS Pharmaceuticals, Inc. | 356.88M | -2.74% | 434,065 | 122.14M |
| 493 | YDES | YD Bio Limited | 354.16M | 5.71% | 16,309 | 1.24M |
| 494 | EMBC | Embecta Corp. | 349.31M | 0.24% | 186,222 | 1.02B |
| 495 | LYEL | Lyell Immunopharma, Inc. | 345.92M | 2.93% | 47,745 | 15.00K |
| 496 | PRLD | Prelude Therapeutics Incorporated | 342.31M | -0.15% | 87,049 | 21.57M |
| 497 | VMD | Viemed Healthcare, Inc. | 339.52M | -1.21% | 54,095 | 310.37M |
| 498 | LRMR | Larimar Therapeutics, Inc. | 339.06M | 7.86% | 952,357 | - |
| 499 | TLRY | Tilray Brands, Inc. | 335.12M | -2.77% | 2,525,821 | 963.10M |
| 500 | CCCC | C4 Therapeutics, Inc. | 333.55M | 0.40% | 1,361,458 | 32.28M |